182 related articles for article (PubMed ID: 34854949)
1. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.
Yao T; Rudak PT; Laumont CM; Michaud AR; Rashu R; Knier NN; Foster PJ; McWilliam HEG; Villadangos JA; Nelson BH; DiMattia GE; Shepherd TG; Haeryfar SMM
Cancer Immunol Immunother; 2022 May; 71(5):1259-1273. PubMed ID: 34854949
[TBL] [Abstract][Full Text] [Related]
2. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
Zumwalde NA; Haag JD; Gould MN; Gumperz JE
Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
[TBL] [Abstract][Full Text] [Related]
3. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
[TBL] [Abstract][Full Text] [Related]
4. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
5. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
Kawachi I; Maldonado J; Strader C; Gilfillan S
J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
[TBL] [Abstract][Full Text] [Related]
6. MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.
Suliman S; Murphy M; Musvosvi M; Gela A; Meermeier EW; Geldenhuys H; Hopley C; Toefy A; Bilek N; Veldsman A; Hanekom WA; Johnson JL; Boom WH; Obermoser G; Huang H; Hatherill M; Lewinsohn DM; Nemes E; Scriba TJ
J Immunol; 2019 Dec; 203(11):2917-2927. PubMed ID: 31611259
[TBL] [Abstract][Full Text] [Related]
7. Classic costimulatory interactions in MAIT cell responses: from gene expression to immune regulation.
Wang NI; Ninkov M; Haeryfar SMM
Clin Exp Immunol; 2023 Jul; 213(1):50-66. PubMed ID: 37279566
[TBL] [Abstract][Full Text] [Related]
8. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL
Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of MR1 regulates antigen presentation to MAIT cells.
Narayanan GA; Nellore A; Tran J; Worley AH; Meermeier EW; Karamooz E; Huber ME; Kurapova R; Tafesse FG; Harriff MJ; Lewinsohn DM
Sci Rep; 2020 Sep; 10(1):15429. PubMed ID: 32963314
[TBL] [Abstract][Full Text] [Related]
10. MR1-Restricted MAIT Cells From The Human Lung Mucosal Surface Have Distinct Phenotypic, Functional, and Transcriptomic Features That Are Preserved in HIV Infection.
Khuzwayo S; Mthembu M; Meermeier EW; Prakadan SM; Kazer SW; Bassett T; Nyamande K; Khan DF; Maharaj P; Mitha M; Suleman M; Mhlane Z; Ramjit D; Karim F; Shalek AK; Lewinsohn DM; Ndung'u T; Wong EB
Front Immunol; 2021; 12():631410. PubMed ID: 33897687
[TBL] [Abstract][Full Text] [Related]
11. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
12. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
13. CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells.
Souter MNT; Awad W; Li S; Pediongco TJ; Meehan BS; Meehan LJ; Tian Z; Zhao Z; Wang H; Nelson A; Le Nours J; Khandokar Y; Praveena T; Wubben J; Lin J; Sullivan LC; Lovrecz GO; Mak JYW; Liu L; Kostenko L; Kedzierska K; Corbett AJ; Fairlie DP; Brooks AG; Gherardin NA; Uldrich AP; Chen Z; Rossjohn J; Godfrey DI; McCluskey J; Pellicci DG; Eckle SBG
J Exp Med; 2022 Sep; 219(9):. PubMed ID: 36018322
[TBL] [Abstract][Full Text] [Related]
14. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
[TBL] [Abstract][Full Text] [Related]
15. New insights into MAIT cells in autoimmune diseases.
Fan Q; Nan H; Li Z; Li B; Zhang F; Bi L
Biomed Pharmacother; 2023 Mar; 159():114250. PubMed ID: 36652733
[TBL] [Abstract][Full Text] [Related]
16. Mucosal-Associated Invariant T Cells Develop an Innate-Like Transcriptomic Program in Anti-mycobacterial Responses.
Sharma M; Zhang S; Niu L; Lewinsohn DM; Zhang X; Huang S
Front Immunol; 2020; 11():1136. PubMed ID: 32582206
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
18. MAIT Cells in COVID-19: Heroes, Villains, or Both?
Haeryfar SMM
Crit Rev Immunol; 2020; 40(2):173-184. PubMed ID: 32749095
[TBL] [Abstract][Full Text] [Related]
19. Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
Dogan M; Karhan E; Kozhaya L; Placek L; Chen X; Yigit M; Unutmaz D
J Immunol; 2022 Oct; 209(8):1523-1531. PubMed ID: 36165183
[TBL] [Abstract][Full Text] [Related]
20. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
